Drug Type Multi-specific antibody |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Modex Therapeutics, Inc.Startup |
Active Organization Modex Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | Modex Therapeutics, Inc.Startup | 01 Jan 2025 |
Infectious Diseases | Preclinical | US | Modex Therapeutics, Inc.Startup | 01 Jan 2025 |
Solid tumor | Preclinical | US | Modex Therapeutics, Inc.Startup | 01 Jan 2025 |